Impact of drug resistance on the tuberculosis treatment outcome
Journal Title: Актуальна інфектологія - Year 2017, Vol 5, Issue 2
Abstract
Background. The standard treatment of a new case of multidrug-resistant tuberculosis (MDR-TB) according to WHO recommendations in the Republic of Moldova is performed since 2005 showing a low treatment succes. Actually the treatment success rate increased due to excluding of MDR-TB patients from the general cohort. The major rate of patients with low outcome is represented by the failed and lost to follow-up cases. The purpose of the study was to assess the impact of multidrug-resiatnce and MDR-TB on the tuberculosis treatment outcome. Materials and methods. A retrospective selective, descriptive study targeting social, demographic, economic and epidemiological peculiarities, case-management, diagnostic radiological aspects and microbiological characteristics of 187 patients with pulmonary tuberculosis registered during 2013–2015 distributed in two groups: 1st group (61 patients) with established multidrug-resistant strains using conventional cultural methods and the 2nd group (126 patients) with MDR-TB. Results. Multidrug-resistance was established more frequently in new cases and MDR-TB in two thirds of retreated patients. No difference was identified in gender and age distribution, social, economical, educational characteristics; case-management assessment identified a similar proportion of patients revealed by general practitioners and specialists, with low rate of screened high risk groups. All patients from the multidrug-resistant group began the standard treatment for drug-responsiveness tuberculosis before drug susceptibility testing and one third of MDR-TB group was treated from the onset with the DOTS-Plus regimen. Highest success rate was identified in the new-case subgroups of both groups and higher rate of died patients was determined in the retreated subgroups. Such a low rate of patients aggrevates the resistance. Conclusions. Early diagnosis, drug responsiveness testing and raising awareness among about treatment compliance will improve disease outcome.
Authors and Affiliations
E. Lesnic, A. Niguleanu, L. Todoriko
Keywords
Related Articles
- EP ID EP213206
- DOI 10.22141/2312-413x.5.2.2017.105319
- Views 99
- Downloads 0
The Use of GenoFibroTest Results in Routine Clinical Practice
The value of GenoFibroTest results for predicting the possibility of achieving sustained virological response in patients with chronic hepatitis C genotype 1 is presented in this article. The results of GenoFibroTest mus...
Endotoxemia in Patients with Liver Cirrhosis
There is a relationship between infection and the severity of endotoxemia in patients with liver cirrhosis (LC). Bacterial or viral or agent, penetrating the body of a patient with LC, triggers a cascade of immune-enzyma...
Influence of HCV-Infection on the Development of Diabetes Mellitus Type 1
The data concerning the influence of HCV-infection on the development of diabetes mellitus are given. It is shown that HCV-infection causes pancreatic lesions in the form of insulitis, lymphoid infiltration with the subs...
Motivation sphere features of patients with psychoendocrine syndrome on the background of hypogonadism
Background. Psychoneuroendocrinology is the clinical study of hormone fluctuations and their relationship to human behavior. It may be viewed from the perspective of psychiatry, where in certain mood disorders, there are...
Unfavorable outcome of herpes meningoencephalitis in an adolescent
A clinical observation of a severe form of herpes meningoencephalitis in 15-year-old adolescent is presented. Late diagnosis of meningoencephalitis and untimely administration of specific antiviral therapy (acyclovir was...